Search research articles
Contact Us
Filters
Showing results (171-180 of 247) with videos related to
Page
of 25
Sort By:
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation
Capucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.
Journal for Immunotherapy of Cancer
|
September 23, 2024
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors
Si Chen, Jiakai Hou, Roshni Jaffery, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> Amplification
Siqing Fu, Shuyang Yao, Yuan Yuan, et al.
International Journal of Molecular Sciences
|
May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
David Capper, Andreas von Deimling, Alba A Brandes, et al.
Nature Reviews. Clinical Oncology
|
January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Amber Johnson, Yifei Shen, Xiaofeng Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Page
of 25
Search research articles
Search
Showing results (171-180 of 247) with videos related to
Sort By:
Page
of 25
JCO Precision Oncology
|
July 24, 2018
Survival Outcomes by <i>TP53</i> Mutation Status in Metastatic Breast Cancer
Funda Meric-Bernstam, Xiaofeng Zheng, Maryam Shariati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 6, 2025
First-in-Human, Phase I/II Dose Escalation and Expansion Study of Zelenectide Pevedotin in Patients With Advanced Solid Tumors: Results From Monotherapy Dose Escalation
Capucine Baldini, Loic Verlingue, Vincent Goldschmidt, et al.
Journal for Immunotherapy of Cancer
|
September 23, 2024
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumors
Si Chen, Jiakai Hou, Roshni Jaffery, et al.
Cancer Research Communications
|
August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 Unit
Camila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
Multicenter Phase II Trial of the WEE1 Inhibitor Adavosertib in Refractory Solid Tumors Harboring <i>CCNE1</i> Amplification
Siqing Fu, Shuyang Yao, Yuan Yuan, et al.
International Journal of Molecular Sciences
|
May 9, 2017
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
David Capper, Andreas von Deimling, Alba A Brandes, et al.
Nature Reviews. Clinical Oncology
|
January 6, 2026
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Amber Johnson, Yifei Shen, Xiaofeng Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer
Timothy P DiPeri, Kurt W Evans, Stephen Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)
Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
Nature Medicine
|
April 24, 2019
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Jordi Rodon, Jean-Charles Soria, Raanan Berger, et al.
Page
of 25